AU2012368815B2 - A composition and use thereof in the treatment of anal rhagades - Google Patents

A composition and use thereof in the treatment of anal rhagades Download PDF

Info

Publication number
AU2012368815B2
AU2012368815B2 AU2012368815A AU2012368815A AU2012368815B2 AU 2012368815 B2 AU2012368815 B2 AU 2012368815B2 AU 2012368815 A AU2012368815 A AU 2012368815A AU 2012368815 A AU2012368815 A AU 2012368815A AU 2012368815 B2 AU2012368815 B2 AU 2012368815B2
Authority
AU
Australia
Prior art keywords
composition
hibiscus
anal
ranges
beta glucan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2012368815A
Other languages
English (en)
Other versions
AU2012368815A1 (en
Inventor
Filippo Bastia
Maurizio SACCOMANNO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
THD SpA
Original Assignee
THD SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46001672&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2012368815(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by THD SpA filed Critical THD SpA
Publication of AU2012368815A1 publication Critical patent/AU2012368815A1/en
Application granted granted Critical
Publication of AU2012368815B2 publication Critical patent/AU2012368815B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/577—Malvaceae (Mallow family)
    • A61K36/5775—Hibiscus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2012368815A 2012-01-30 2012-01-30 A composition and use thereof in the treatment of anal rhagades Active AU2012368815B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2012/000027 WO2013114410A1 (en) 2012-01-30 2012-01-30 A composition and use thereof in the treatment of anal rhagades

Publications (2)

Publication Number Publication Date
AU2012368815A1 AU2012368815A1 (en) 2014-09-18
AU2012368815B2 true AU2012368815B2 (en) 2018-03-01

Family

ID=46001672

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2012368815A Active AU2012368815B2 (en) 2012-01-30 2012-01-30 A composition and use thereof in the treatment of anal rhagades

Country Status (23)

Country Link
US (1) US9345747B2 (OSRAM)
EP (1) EP2646039B1 (OSRAM)
JP (1) JP5903505B2 (OSRAM)
KR (1) KR101599447B1 (OSRAM)
CN (2) CN104114177A (OSRAM)
AU (1) AU2012368815B2 (OSRAM)
BR (1) BR112014018850A8 (OSRAM)
CA (1) CA2863369C (OSRAM)
DK (1) DK2646039T3 (OSRAM)
ES (1) ES2485490T3 (OSRAM)
HR (1) HRP20140594T1 (OSRAM)
IL (1) IL233875A (OSRAM)
IN (1) IN2014MN01733A (OSRAM)
MX (1) MX336204B (OSRAM)
PL (1) PL2646039T3 (OSRAM)
RS (1) RS53457B (OSRAM)
RU (1) RU2580622C2 (OSRAM)
SA (1) SA113340239B1 (OSRAM)
SG (1) SG11201404413UA (OSRAM)
SI (1) SI2646039T1 (OSRAM)
TW (1) TWI495476B (OSRAM)
WO (1) WO2013114410A1 (OSRAM)
ZA (1) ZA201405208B (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6523291B2 (ja) 2013-12-24 2019-05-29 ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ スキンケア有効成分の高い浸透性を与える美容組成物及び方法
ITRM20150163A1 (it) * 2015-04-17 2016-10-17 Uniderm Farm S R L Composizioni farmaceutiche per il trattamento delle ragadi anali
US10117826B2 (en) 2016-03-31 2018-11-06 Peter Angia Pham Bodily lubricating and moisturizing compositions containing plant mucilage
US10835504B2 (en) 2018-04-18 2020-11-17 G&S Laboratories, Inc. Compositions to treat anal itch
WO2020022991A2 (en) * 2018-05-02 2020-01-30 Montero Gida Sanayi Ve Ticaret Anonim Sirketi Topical compositions for stretch marks on the skin
RU2771015C2 (ru) * 2020-09-25 2022-04-25 Общество с ограниченной ответственностью "ФАРМКОММ" Фармацевтическая композиция в виде мази для лечения геморроя

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994004163A1 (en) * 1992-08-21 1994-03-03 Alpha-Beta Technology, Inc. Novel glucan preparation
WO1998046205A1 (fr) * 1997-04-16 1998-10-22 Laboratoires Serobiologiques (Societe Anonyme) Utilisation d'une fraction proteique extraite de graines d'hibiscus esculentus en cosmetique
JP2004051533A (ja) * 2002-07-19 2004-02-19 Ichimaru Pharcos Co Ltd ヒアルロン酸合成促進剤
US6956120B2 (en) * 2000-11-09 2005-10-18 Yasushi Onaka β-1.3-1.6 glucan (Aureobasidium medium)
US20060093657A1 (en) * 2004-11-04 2006-05-04 Biofarmitalia S.P.A. Patch containing a substance selected from tars having reducing characteristics in dermatology
DE202007004856U1 (de) * 2007-04-01 2007-06-06 Rühle, Wilfried, Dipl.-Ing. CHM Anti Aging Komplex
US20090202664A1 (en) * 2008-02-11 2009-08-13 Svetislav Mikalacki Herbal cream or oil for the treatment hemorroids and wounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6379719B1 (en) * 1998-04-08 2002-04-30 Laboratories Serobiologiques (Societe Anonyme) Use of at least one protein fraction extracted from Hibiscus esculentus seeds and cosmetic composition containing such a fraction
CN1233469A (zh) * 1998-04-28 1999-11-03 王京杭 组织修复促进剂
JP2002204687A (ja) * 2000-11-09 2002-07-23 Onaka Yasushi β−１．３−１．６グルカン（アウレオバシジウム培養液）の医療、保健、福祉、食品および各種産業分野での応用
JP2003104832A (ja) * 2001-09-28 2003-04-09 Chifure Keshohin:Kk 皮膚外用剤
WO2004096242A1 (en) * 2003-05-02 2004-11-11 Ceapro Inc. Pharmaceutical compositions comprising cereal beta (1-3) beta (1-4) glucan
RU2277920C2 (ru) * 2004-02-24 2006-06-20 Государственное Учреждение "Пятигорский Государственный Научно-Исследовательский Институт Курортологии Министерства Здравоохранения Российской Федерации" Способ лечения детей, больных хроническим вирусным гепатитом, с применением сульфидных ванн и слабоуглекислой минеральной водой
JP5048935B2 (ja) * 2005-08-24 2012-10-17 株式会社ヤクルト本社 保湿剤
CN101095482B (zh) * 2007-07-05 2012-02-15 中国科学院长春应用化学研究所 制备膳食纤维食品用大麦麦麸或燕麦麦麸的制法
ITUD20100112A1 (it) * 2010-06-09 2011-12-10 Farma Derma S R L Preparazione per uso vaginale e rettale e relativo procedimento di produzione
CN102084963A (zh) * 2010-09-29 2011-06-08 吉林省农业机械研究院 一种制备燕麦麦麸膳食纤维食品的方法

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994004163A1 (en) * 1992-08-21 1994-03-03 Alpha-Beta Technology, Inc. Novel glucan preparation
WO1998046205A1 (fr) * 1997-04-16 1998-10-22 Laboratoires Serobiologiques (Societe Anonyme) Utilisation d'une fraction proteique extraite de graines d'hibiscus esculentus en cosmetique
US6956120B2 (en) * 2000-11-09 2005-10-18 Yasushi Onaka β-1.3-1.6 glucan (Aureobasidium medium)
JP2004051533A (ja) * 2002-07-19 2004-02-19 Ichimaru Pharcos Co Ltd ヒアルロン酸合成促進剤
US20060093657A1 (en) * 2004-11-04 2006-05-04 Biofarmitalia S.P.A. Patch containing a substance selected from tars having reducing characteristics in dermatology
DE202007004856U1 (de) * 2007-04-01 2007-06-06 Rühle, Wilfried, Dipl.-Ing. CHM Anti Aging Komplex
US20090202664A1 (en) * 2008-02-11 2009-08-13 Svetislav Mikalacki Herbal cream or oil for the treatment hemorroids and wounds

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BRYANT L A ET AL, JOURNAL OF FOOD SCIENCE, (19880101), vol. 53, no. 3, pages 810 - 816 *

Also Published As

Publication number Publication date
CN104114177A (zh) 2014-10-22
US9345747B2 (en) 2016-05-24
AU2012368815A1 (en) 2014-09-18
PL2646039T3 (pl) 2014-10-31
WO2013114410A1 (en) 2013-08-08
BR112014018850A2 (OSRAM) 2017-06-20
RU2014129391A (ru) 2016-03-27
JP5903505B2 (ja) 2016-04-13
SI2646039T1 (sl) 2014-10-30
DK2646039T3 (da) 2014-08-11
CA2863369A1 (en) 2013-08-08
ZA201405208B (en) 2015-10-28
KR20140127296A (ko) 2014-11-03
JP2015504915A (ja) 2015-02-16
IL233875A0 (en) 2014-09-30
MX2014009244A (es) 2015-03-19
US20140303094A1 (en) 2014-10-09
HRP20140594T1 (hr) 2014-10-24
BR112014018850A8 (pt) 2017-07-11
IN2014MN01733A (OSRAM) 2015-07-10
ES2485490T3 (es) 2014-08-13
TWI495476B (zh) 2015-08-11
CN109865000A (zh) 2019-06-11
HK1186378A1 (en) 2014-03-14
SA113340239B1 (ar) 2015-07-07
RS53457B (en) 2014-12-31
EP2646039B1 (en) 2014-05-14
SG11201404413UA (en) 2014-10-30
IL233875A (en) 2017-01-31
RU2580622C2 (ru) 2016-04-10
TW201334787A (zh) 2013-09-01
EP2646039A1 (en) 2013-10-09
MX336204B (es) 2016-01-11
CA2863369C (en) 2020-03-10
KR101599447B1 (ko) 2016-03-14

Similar Documents

Publication Publication Date Title
AU2012368815B2 (en) A composition and use thereof in the treatment of anal rhagades
JP6121561B2 (ja) 組織再生のための組成物および方法
EA032439B1 (ru) Композиции и способы для лечения поверхностных ран
JP7664689B2 (ja) 外用組成物
BR112021003877A2 (pt) composições farmacêuticas à base de óleo semissólidas que contêm pirfenidona para aplicação em reparo tecidual
KR20120118064A (ko) 염증후 과다색소침착의 감소로 비코카서스인 모집단에서의 여드름 치료를 위한 아다팔렌과 벤조일 퍼옥사이드의 조합물을 포함하는 피부용 조성물
CN103347507A (zh) 用于治疗痤疮的褪黑激素以及抗微生物剂或抗菌剂
US11696907B2 (en) Wound healing composition
WO2004100923A1 (fr) Composition a usage externe administree par voie percutanee
US20020176876A1 (en) Topical therapeutic skin care system
EP3087993B1 (en) Pharmaceutical composition comprising acetyl hexapeptide-8 and pentapeptide-18 for treating anal fissures
US20180296611A1 (en) Topical Medicament for skin and mucosal injuries
US20040109899A1 (en) Antiviral medicament and method for producing and using the same for the prophylactic and therapeutic treatment of papillomavirus induced tumors, lesions and deseases
HK1186378B (en) A composition and use thereof in the treatment of anal rhagades
KR100892742B1 (ko) 여드름 치료용 피부 외용제 조성물
CN114306107A (zh) 功效型皮肤用产品及其制备方法
Gregoriou et al. Efficacy and tolerance of a prebiotic, panthenol-containing repair balm in patients diagnosed with skin lesions requiring regenerative care
JP7690469B2 (ja) ヒアルロン酸産生促進剤およびコラーゲン産生促進剤
JP2016033137A (ja) 裂肛の治療における組成物及びその使用
EP3081212A1 (en) Carboxymethylcysteine for topical treatment of stretch marks
EP4593859A1 (en) Combination treatment of dermal and transdermal fibrotic diseases, disorders and associated pain and inflammation
CN120643673A (zh) 一种促进术后伤口愈合的漱口水及其制备方法
US20090111783A1 (en) Dermatological compositions comprising hydroquinone, fluocinolone acetonide and tretinoin for treating the hyperpigmentation of pathological scars

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)